AB

Adamant Biomedical Investments AG

Diversified strategySector-focusedMomentum follower

Total reported value

$418.4M

Reporting period: 2014-12-31 · Number of holdings: 101

Adamant Biomedical Investments AG disclosed 101 holdings in its latest 13F filing for the period ending 2014-12-31, with total reported value of $418.4M and a quarterly turnover rate of 32.4%.

Personality snowflake

Concentration
7.73
Portfolio Stability
32.41
Momentum/Contrarian
100
Sector conviction
100
Diversification
100
Sizing Uniformity
90.2

Recent moves

  • Trim 795435106

    -42.5%　-$7.0M

  • Add ACAD

    +485.7%　$5.6M

  • Add 148887102

    +51.3%　$5.5M

  • Trim GILD

    -8.1%　-$3.9M

  • Add MODV

    +225.0%　$4.5M

  • Trim G2554F113

    -83.3%　-$4.2M

Holdings Map

New buyAddUnchangedTrim

Top 10 holdings by weight

Full holdings list this quarter

#TickerIssuerAsset SubclassWeightWeight ChangeShares Change4Q Trend
1CELGCelgene CORPStock-Other4.98%+0.09%-9.94%
2BIIBBiogen INCStock-Healthcare4.32%—-3.22%
3GILDGilead Sciences INCStock-Healthcare4.06%-1.16%-8.15%
4AMGNAmgen INCStock-Healthcare3.62%+0.11%-5.00%
5✓ Stock-Other3.17%+0.03%-1.00%
6UNHUnitedhealth Group INCStock-Healthcare2.78%—-10.16%
7✓ Stock-Other2.69%+0.08%-13.04%
8✓ Stock-Other2.57%+1.26%+51.25%
9ALXNAlexion Pharmaceuticals INCStock-Other2.52%—-5.00%
10MDTMedtronic plcStock-Healthcare2.10%—-19.00%
11VRTXVertex Pharmaceuticals INCStock-Healthcare2.07%——
12REGNRegeneron PharmaceuticalsStock-Healthcare2.06%+0.44%+16.67%
13MCKMckesson CORPStock-Healthcare2.03%——
14✓ Auris Med Hldg AGStock-Other2.02%-0.48%—
15✓ Mallinckrodt PLCStock-Other1.89%+0.09%—
16ABTAbbott LaboratoriesStock-Healthcare1.86%—-13.50%
17✓ Allergan INCStock-Other1.78%+0.22%—
18ILMNIllumina INCStock-Healthcare1.76%—-6.98%
19ACADAcadia Pharmaceuticals INCStock-Healthcare1.56%+1.34%+485.71%
20MODVModivCare Inc.Stock-Other1.55%+1.06%+225.00%
21CAHCardinal Health INCStock-Healthcare1.54%-0.42%-23.81%
22✓ Isis Pharmaceuticals INCStock-Other1.48%+0.12%-28.57%
23AKRXEURAkorn INCStock-Other1.38%+0.84%+166.67%
24LLYEli Lilly & CoStock-Healthcare1.32%——
25✓ Stock-Other1.32%+1.32%NEW
26CNCCentene CORPStock-Healthcare1.28%-0.34%-34.22%
27✓ Salix Pharmaceuticals INCStock-Other1.24%-1.81%-42.46%
28CIThe Cigna GroupStock-Healthcare1.23%——
29INCYIncyte CORPStock-Healthcare1.22%+0.36%—
30MOHMolina Healthcare INCStock-Healthcare1.17%—-30.02%
31AXPAmerican Express CompanyStock-Financials1.15%+0.15%—
32BAXBaxter International INCStock-Healthcare1.14%——
33BKDBrookdale Senior Living INCStock-Other1.14%—-5.87%
34✓ Wuxi Pharmatech Cayman INCStock-Other1.13%+1.13%NEW
35LGNDLigand PharmaceuticalsStock-Healthcare1.03%+1.03%NEW
36HUMHumana INCStock-Healthcare1.03%—-14.29%
37JNJJohnson & JohnsonStock-Healthcare1.00%—-11.11%
38LN5Lannett Co INCStock-Other0.97%—+17.76%
39HCAHca Healthcare INCStock-Healthcare0.96%+0.17%+22.22%
40ABBVAbbvie INCStock-Healthcare0.94%+0.94%NEW
41SYKStryker CORPStock-Healthcare0.94%-0.22%-27.83%
42✓ Stock-Other0.93%-0.28%-26.67%
43ELVElevance Health INCStock-Healthcare0.90%+0.90%NEW
44BMYBristol-myers Squibb CoStock-Healthcare0.85%+0.21%+20.00%
45PRGOPerrigo Company plcStock-Healthcare0.80%-0.24%-34.96%
46✓ St Jude Med INCStock-Other0.79%—-21.54%
47JAZZJazz Pharmaceuticals plcStock-Healthcare0.78%——
48BMRNBiomarin Pharmaceutical INCStock-Healthcare0.78%—-28.00%
49CVSCvs Health CORPStock-Healthcare0.69%-0.20%-33.33%
50✓ Stock-Other0.69%——
1–50 of 101

Holding changes this quarter

Adamant Biomedical Investments AG's most significant position changes for 2014-12-31: New buy: ; New buy: Wuxi Pharmatech Cayman INC; Sold out: ; New buy: Ligand Pharmaceuticals (LGND); New buy: Abbvie INC (ABBV).

Position changes disclosed by Adamant Biomedical Investments AG for the quarter ending 2014-12-31, including ticker, issuer, weight change, shares change, and action
#TickerIssuerWeight ChangeShares ChangeAction
1ACADAcadia Pharmaceuticals INC+1.3%+485.71%Add
2✓ +1.3%+51.25%Add
3MODVModivCare Inc.+1.1%+225.00%Add
4AKRXEURAkorn INC+0.8%+166.67%Add
5REGNRegeneron Pharmaceuticals+0.4%+16.67%Add
6INCYIncyte CORP+0.4%—Unchanged
7✓ Allergan INC+0.2%—Unchanged
8BMYBristol-myers Squibb Co+0.2%+20.00%Add
9✓ Cubist Pharmaceuticals INC+0.2%—Unchanged
10HCAHca Healthcare INC+0.2%+22.22%Add
11AXPAmerican Express Company+0.2%—Unchanged
12ALKSAlkermes plc+0.2%—Unchanged
13✓ Isis Pharmaceuticals INC+0.1%-28.57%Trim
14AMGNAmgen INC+0.1%-5.00%Trim
15CELGCelgene CORP+0.1%-9.94%Trim
16✓ Mallinckrodt PLC+0.1%—Unchanged
17✓ +0.1%-13.04%Trim
18✓ 0%-1.00%Trim
19CVSCvs Health CORP-0.2%-33.33%Trim
20SYKStryker CORP-0.2%-27.83%Trim
21PRGOPerrigo Company plc-0.2%-34.96%Trim
22UTHRUnited Therapeutics CORP-0.3%-53.33%Trim
23✓ -0.3%-26.67%Trim
24TBPHTheravance Biopharma, Inc.-0.3%-65.00%Trim
25CNCCentene CORP-0.3%-34.22%Trim
26CAHCardinal Health INC-0.4%-23.81%Trim
27RDYDr. Reddy's Laboratories-adr-0.5%-37.50%Trim
28RMDResmed INC-0.5%-66.36%Trim
29✓ Auris Med Hldg AG-0.5%—Unchanged
30QGENQiagen N.V.-0.7%-60.10%Trim
31BIBProshares Ultra Nasd Biotech-0.9%-70.00%Trim
32TEVATeva Pharmaceutical-sp Adr-0.9%-58.33%Trim
33✓ -1.1%-83.33%Trim
34GILDGilead Sciences INC-1.2%-8.15%Trim
35✓ Salix Pharmaceuticals INC-1.8%-42.46%Trim
36✓ —NEWNew buy
37✓ Wuxi Pharmatech Cayman INC—NEWNew buy
38✓ —EXITSold out
39LGNDLigand Pharmaceuticals—NEWNew buy
40ABBVAbbvie INC—NEWNew buy
41ELVElevance Health INC—NEWNew buy
42PODDInsulet CORP—EXITSold out
43CLVSEURClovis Oncology INC—NEWNew buy
44RVNCEURRevance Therapeutics INC—EXITSold out
45✓ Parexel Intl CORP—NEWNew buy
46TNADir Dai Sml Ca Bul 3x Et-usd—EXITSold out
47THCTenet Healthcare CORP—NEWNew buy
48LOWLowe's Companies, Inc.—NEWNew buy
49✓ Wright Med Group INC—EXITSold out
50✓ Ldr Hldg CORP—EXITSold out

FAQ

What is Adamant Biomedical Investments AG and what type of investor is it?
Adamant Biomedical Investments AG is a investment manager that files SEC Form 13F quarterly, disclosing its U.S. public equity holdings to regulators. As of the most recent reporting period (2014-12-31), the firm manages a tracked equity portfolio valued at approximately $418.4M, spread across 101 disclosed positions.
What are Adamant Biomedical Investments AG's largest equity positions?
Based on the latest 13F filing, Adamant Biomedical Investments AG's top holdings by market value are: 1. Celgene CORP (CELG) — $20.8M (5.0%) 2. Biogen INC (BIIB) — $18.1M (4.3%) 3. Gilead Sciences INC (GILD) — $17.0M (4.1%) 4. Amgen INC (AMGN) — $15.1M (3.6%) 5. — $13.3M (3.2%)
What changes did Adamant Biomedical Investments AG make in its most recent portfolio filing?
In the latest reported quarter, Adamant Biomedical Investments AG made 43 notable position adjustments: 9 new positions were initiated, 7 existing holdings were added to, 21 positions were partially reduced, and 6 were completely exited. The largest of these moves: New buy: ; New buy: Wuxi Pharmatech Cayman INC; Sold out: ; New buy: Ligand Pharmaceuticals (LGND); New buy: Abbvie INC (ABBV)
What sectors does Adamant Biomedical Investments AG focus on?
Adamant Biomedical Investments AG is concentrated in the following sectors based on its current disclosed equity portfolio: • Health Care: 95.2% • Financials: 3.6% • Consumer Discretionary: 1.2%